SLC3A2 and nonpapillary renal cell carcinoma: As shown in Fig. 2D, only 20 (4.98%) of 402 ccRCC patients had somatic mutation, and ACTN4, SLC3A2, NDUFS1, and TLN1 had a 1% incidence of missense mutation.